RAMM Pharma Corp. (CSE:RAMM)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
At close: Mar 20, 2026
RAMM Pharma Revenue
In the fiscal year ending October 31, 2025, RAMM Pharma had annual revenue of 3.36M CAD, down -22.60%. RAMM Pharma had revenue of 605.66K in the quarter ending October 31, 2025, a decrease of -40.70%.
Revenue
3.36M
Revenue Growth
-22.60%
P/S Ratio
0.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 3.36M | -981.34K | -22.60% |
| Oct 31, 2024 | 4.34M | -723.29K | -14.28% |
| Oct 31, 2023 | 5.07M | 1.17M | 29.96% |
| Oct 31, 2022 | 3.90M | -218.63K | -5.31% |
| Oct 31, 2021 | 4.12M | -1.33M | -24.40% |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayurcann Holdings | 31.28M |
| 1933 Industries | 17.42M |
| Adastra Holdings | 16.86M |
| CanadaBis Capital | 15.08M |
| Vencanna Ventures | 3.60M |
| Aion Therapeutic | 1.47M |
| Ovation Science | 63.82K |
| Genix Pharmaceuticals | 68.00 |